Amanote Research

Amanote Research

    RegisterSign In

Treatment of Myasthenia--I.

BMJ
doi 10.1136/bmj.2.5754.160
Full Text
Open PDF
Abstract

Available in full text

Date

April 17, 1971

Authors

Unknown

Publisher

BMJ


Related search

Treatment for Refractory Myasthenia Gravis.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1989English

Ephedrine Treatment for Autoimmune Myasthenia Gravis

Neuromuscular Disorders
Child HealthNeurologyPediatricsPerinatologyGenetics
2017English

Role of Rituximab in Myasthenia Gravis’ Treatment

Journal of Neurology & Stroke
2017English

Escalation Strategies in the Treatment of Refractory Myasthenia Gravis

Neurology International Open
2018English

Long-Term Treatment of Refractory Myasthenia Gravis With Subcutaneous Immunoglobulin

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2017English

Myasthenia Gravis Exacerbation and Diarrhea Associated With Erythromycin Treatment

Journal of Acute Disease
Medicine
2017English

Ocular Myasthenia Associated With Thyamus Hyperplasia: Peculiarities of Diagnostics and Treatment

Clinical & experimental pathology
2019English

Subcutaneous Immunoglobulins Are a Valuable Treatment Option in Myasthenia Gravis

Journal of Clinical Neurology (Korea
Neurology
2018English

Failure of Treatment of Myasthenia Gravis by Cyclosporin-A: A Case Report

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
1989English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy